Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chikungunya virus drug discovery: still a long way to go?

10 Jun 2019

Abstract excerpt

Introduction: Chikungunya virus (CHIKV) is the etiological agent of a (re)emerging arbovirus infection, chikungunya fever (CHIKF), that represents a serious health problem worldwide for which no antivirals are available.Areas covered: This review covers the efforts performed so far to identify and optimize small molecules that could be useful as antivirals for CHIKV infection, including drug repositioning,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mosquito-borne diseases and control
Share to Viral Infections and Outbreaks Research
Share to Viral Infections and Vectors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31177861
DOI: 10.1080/17460441.2019.1629413

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chikungunya virus drug discovery: still a long way to go?PMID 31177861Read ↗

Identification and Characterization of Novel Chikungunya Virus Polymerase InhibitorsSemantic proximity Read ↗

Characterization of the RNA-dependent RNA polymerase from Chikungunya virus and discovery of a novel ligand as a potential drug candidateSemantic proximity Read ↗

Novel Class of Chikungunya Virus Small Molecule Inhibitors That Targets the Viral Capping MachinerySemantic proximity Read ↗

Chikungunya virus: recent advances in epidemiology, host pathogen interaction and vaccine strategiesSemantic proximity Read ↗

Evolution and immunopathology of chikungunya virus informs therapeutic development.Semantic proximity Read ↗

Discovery of small molecule inhibitors of chikungunya virus proteins (nsP2 and E1) using in silico approachesSemantic proximity Read ↗

Drug repurposing approach against chikungunya virus: an in vitro and in silico studySemantic proximity Read ↗

Chikungunya virus: an update on antiviral development and challengesSemantic proximity Read ↗

Drugs targeting structural and nonstructural proteins of the chikungunya virus: A reviewSemantic proximity Read ↗

The Interplay of Viral and Host Factors in Chikungunya Virus Infection: Targets for Antiviral StrategiesSemantic proximity Read ↗

The global emergence of Chikungunya infection: An integrated viewSemantic proximity Read ↗

A human genome-wide loss-of-function screen identifies effective chikungunya antiviral drugsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.